2020
DOI: 10.1016/j.jksus.2020.01.021
|View full text |Cite
|
Sign up to set email alerts
|

Repositioning of strongly integrated drugs against achromatopsia (CNGB3)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…However, fewer number of bumps or errors i.e. one or two are negligible ( Zainab et al, 2020 ).
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…However, fewer number of bumps or errors i.e. one or two are negligible ( Zainab et al, 2020 ).
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…However, LD50 alone does not indicate the extent of the toxicity and cannot be equivalent to acute toxicity. Rather, it only indicates the toxicity of a compound 107 . Chronic toxicity will be the ability of a chemical to cause damage following repeated exposure to relatively low doses for a long time.…”
Section: Toxicity Definitionsmentioning
confidence: 99%